UMED develops precision technology for the urology sector, aiming to improve diagnostics and treatment. The company focuses on creating a platform for digital health and data collection to increase accessibility to medical care.
Funding
$12.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods of bladder irrigation and drug instillation for urological conditions often lack precision, consistency, and automation, potentially leading to inconsistent treatment outcomes and increased burden on healthcare providers and patients. Existing Foley catheters may not effectively deliver drugs to the urethra, and preventing drug leakage remains a challenge.
Solution
UMED develops and commercializes innovative medical devices for urology, focusing on improving the precision, automation, and comfort of bladder irrigation and drug instillation. Their UroRinse system provides automated intermittent bladder irrigation with customizable cleaning modes based on bladder capacity, ensuring consistent and reproducible procedures. The UROALL catheter features a unique micro-pore membrane for effective intraurethral drug delivery, while the UROALL Cap prevents drug leakage, enhancing treatment efficiency and patient comfort. UMED's solutions aim to standardize cystostomies, optimize drug delivery, and minimize discomfort associated with urological procedures.
Target Audience
UMED's products target urologists, hospitals, and patients requiring bladder irrigation or intraurethral drug instillation, particularly those with urethral strictures or undergoing transurethral procedures.
Features
- UroRinse Light: Automatic Intermittent Bladder Irrigation System with automated bladder volume measurement and tube cleaning modes.
- UroRinse: Employs quantitative peristaltic pumps for controlled infusion and discharge, enabling customized cleaning profiles.
- UROALL Catheter: Features a micro-pore membrane for direct drug instillation to the urethra, applicable for liquid and gel formulations.
- UROALL Catheter: Manufactured with Bi-Fi Free® Tech, a patented Foley catheter technology using synthesized silicone and ZnO polymer for high biological stability.
- UROALL Cap: A condom-like device made of adhesive medical-grade silicone to prevent drug leakage from the urethra, featuring an anti-slip ring for catheter traction.
- Real-world data logging and BLE connectivity for UroRinse, enabling data backup, optimized bladder cleaning algorithms, and future integration with active patient care systems.